col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: EMBO

132 Results       Page 1

 [1] 
  original article Journal Date Title Authors Max. 6 Authors
1 [GO] EMBO Molecular Medicine 2023―Nov―15 Acquired immunity against SARS-CoV-2 infection and vaccination Laurent Renia, Lisa FP Ng
2 [GO] EMBO Reports 2023―Nov―02 Antibody-mediated SARS-CoV-2 entry in cultured cells Md Golam Kibria, Christy L Lavine, Weichun Tang, Shaowei Wang, Hailong Gao, Wei Shi, Haisun Zhu, Jewel Voyer, Sophia Rits-Volloch,   Keerti, Caihong Bi, Hanqin Peng, Duane R Wesemann, Jianming Lu, Hang Xie, Michael S Seaman, Bing Chen
3 [GO] EMBO Reports 2023―Oct―23 ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS Martin Müller, Alexandra Herrmann, Shigeru Fujita, Keiya Uriu, Carolin Kruth, Adam Strange, Jan E Kolberg, Markus Schneider, Jumpei Ito, Marcel A Müller, Christian Drosten, Armin Ensser, Kei Sato, Daniel Sauter
4 [GO] EMBO Reports 2023―Oct―12 Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children Vladimir G Magalhães, Sören Lukassen, Maike Drechsler, Jennifer Loske, Sandy S Burkart, Sandra Wüst, Eva-Maria Jacobsen, Jobst Röhmel, Marcus A Mall, Klaus-Michael Debatin, Roland Eils, Stella Autenrieth, Aleš Janda, Irina Lehmann, Marco Binder
5 [GO] EMBO Reports 2023―Oct―12 Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release Hazel Stewart, Roberta Palmulli, Kristoffer H Johansen, Naomi McGovern, Ola M Shehata, George W Carnell, Hannah K Jackson, Jin S Lee, Jonathan C Brown, Thomas Burgoyne, Jonathan L Heeney, Klaus Okkenhaug, Andrew E Firth, Andrew A Peden, James R Edgar
6 [GO] EMBO Molecular Medicine 2023―Aug―03 Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection Liqiang Zhang, Yize (Henry) Li, Karen Kibler, Simona Kraberger, Arvind Varsani, Julie Turk, Nora Elmadbouly, Emily Aliskevich, Laurel Spaccarelli, Bereket Estifanos, Junior Enow, Isabela Rivabem Zanetti, Nicholas Saldevar, Efrem Lim, Jessika Schlievert, Kyle Browder, Anjali Wilson, Fernando Arcos Juan, Aubrey Pinteric, Aman Garg, Henna Monder, Rohan Saju, Savanah Gisriel, Bertram Jacobs, Timothy L Karr, Esther Borges Florsheim, Vivek Kumar, John Wallen, Masmudur Rahman, Grant McFadden, Brenda G Hogue, Alexandra R Lucas
7 [GO] EMBO Molecular Medicine 2023―Jul―31 Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation Lisa Schweizer, Tina Schaller, Maximilian Zwiebel, Özge Karayel, Johannes Bruno Müller-Reif, Wen-Feng Zeng, Sebastian Dintner, Thierry M Nordmann, Klaus Hirschbühl, Bruno Märkl, Rainer Claus, Matthias Mann
8 [GO] EMBO Molecular Medicine 2023―May―22 Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc Pei-Shan Sung, Cheng-Pu Sun, Mi-Hua Tao, Shie-Liang Hsieh
9 [GO] EMBO Reports 2023―May―15 Antiviral activity of the human endogenous retrovirus-R envelope protein against SARS-CoV-2 Shabnam Ansari, Nidhi Gupta, Rohit Verma, Oinam N Singh, Jyoti Gupta, Amit Kumar, Mukesh Kumar Yadav, Akshay Binayke, Mahima Tiwari, Neha Periwal, Vikas Sood, Shailendra Mani, Amit Awasthi,   Shalimar, Baibaswata Nayak, CT Ranjith-Kumar, Milan Surjit
10 [GO] EMBO Reports 2023―Mar―23 Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparedness Dan Lou, Matthias Meurer, Svetlana Ovchinnikova, Robin Burk, Anna Denzler, Konrad Herbst, Ioannis A Papaioannou, Yuanqiang Duan, Max L Jacobs, Victoria Witte, Daniel Ürge, Daniel Kirrmaier, Michelle Krogemann, Krisztina Gubicza, Kathleen Boerner, Christian Bundschuh, Niklas M Weidner, Uta Merle, Britta Knorr, Andreas Welker, Claudia M Denkinger, Paul Schnitzler, Hans-Georg Kräusslich, Viet Loan Dao Thi, Manuela De Allegri, Hoa Thi Nguyen, Andreas Deckert, Simon Anders, Michael Knop
11 [GO] EMBO Molecular Medicine 2023―Mar―22 Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses Valeria Fumagalli, Pietro Di Lucia, Micol Ravà, Davide Marotta, Elisa Bono, Stefano Grassi, Lorena Donnici, Rolando Cannalire, Irina Stefanelli, Anastasia Ferraro, Francesca Esposito, Elena Pariani, Donato Inverso, Camilla Montesano, Serena Delbue, Stanley Perlman, Enzo Tramontano, Raffaele De Francesco, Vincenzo Summa, Luca G Guidotti, Matteo Iannacone
12 [GO] Molecular Systems Biology 2023―Mar―15 A methylation clock model of mild SARS-CoV -2 infection provides insight into immune dysregulation Weiguang Mao, Clare M Miller, Venugopalan D Nair, Yongchao Ge, Mary Anne S Amper, Antonio Cappuccio, Mary-Catherine George, Carl W Goforth, Kristy Guevara, Nada Marjanovic, German Nudelman, Hanna Pincas, Irene Ramos, Rachel S G Sealfon, Alessandra Soares-Schanoski, Sindhu Vangeti, Mital Vasoya, Dawn L Weir, Elena Zaslavsky, Vanessa Barcessat, Kevin Tuballes, Diane Marie Del Valle, Kai Nie, Hui Xie, Grace Chung, Manishkumar Patel, Jocelyn Harris, Kimberly Argueta, Jacques Fehr, Barr Gruberg, Nicholas Zaki, Seunghee Kim-Schulze, Sacha Gnjatic, Miriam Merad, Andrew G Letizia, Olga G Troyanskaya, Stuart C Sealfon, Maria Chikina
13 [GO] EMBO Reports 2023―Mar―07 Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice Adam D Kenney, Ashley Zani, Jeffrey Kawahara, Adrian C Eddy, Xiao-Liang Wang, KC Mahesh, Mijia Lu, Jeronay Thomas, Jacob E Kohlmeier, Mehul S Suthar, Emily A Hemann, Jianrong Li, Mark E Peeples, Luanne Hall-Stoodley, Adriana Forero, Chuanxi Cai, Jianjie Ma, Jacob S Yount
14 [GO] EMBO Reports 2023―Mar―06 SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19 Sarah Temmam, Xavier Montagutelli, Cécile Herate, Flora Donati, Béatrice Regnault, Mikael Attia, Eduard Baquero Salazar, Delphine Chretien, Laurine Conquet, Grégory Jouvion, Juliana Pipoli Da Fonseca, Thomas Cokelaer, Faustine Amara, Francis Relouzat, Thibaut Naninck, Julien Lemaitre, Nathalie Derreudre-Bosquet, Quentin Pascal, Massimiliano Bonomi, Thomas Bigot, Sandie Munier, Felix A Rey, Roger Le Grand, Sylvie van der Werf, Marc Eloit
15 [GO] EMBO Reports 2023―Mar―06 Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, Xinhua Cao, Ying Miao, Yukang Yuan, Yanli Liu, Feng Ma, Jianfeng Dai, Sheng Tian, Qiang Ding, Hui Zheng
16 [GO] EMBO Reports 2023―Mar―06 Low hanging fruit for combatting SARS-CoV-2? Diego Cantoni, Joe Grove
17 [GO] The EMBO Journal 2022―Dec―15 Host range and structural analysis of bat-origin RshSTT182 /200 coronavirus binding to human ACE2 and its animal orthologs Yu Hu, Kefang Liu, Pu Han, Zepeng Xu, Anqi Zheng, Xiaoqian Pan, Yunfei Jia, Chao Su, Lingfeng Tang, Lili Wu, Bin Bai, Xin Zhao, Tian Di, Zhihai Chen, Jianxun Qi, Qihui Wang, George F. Gao
18 [GO] EMBO Reports 2022―Oct―26 Nsp16 shields SARS-CoV -2 from efficient MDA5 sensing and IFIT1 -mediated restriction Alina Russ, Sabine Wittmann, Yuta Tsukamoto, Alexandra Herrmann, Janina Deutschmann, Justine Lagisquet, Armin Ensser, Hiroki Kato, Thomas Gramberg
19 [GO] The EMBO Journal 2022―Sep―26 Cyclin D3 restricts SARS-CoV -2 Envelope incorporation into virions and interferes with viral spread. Ravi K. Gupta, Petra Mlcochova
20 [GO] The EMBO Journal 2022―Sep―20 Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV -2 entry into human cells Alejandro P. Ugalde, Gabriel Bretones, David Rodríguez, Víctor Quesada, Francisco Llorente, Raúl Fernández-Delgado, Miguel Ángel Jiménez-Clavero, Jesús Vázquez, Enrique Calvo, Isaac Tamargo-Gómez, Guillermo Mariño, David Roiz-Valle, Daniel Maeso, Miguel Araujo-Voces, Yaiza Español, Carles Barceló, José M.P. Freije, Alejandro López-Soto, Carlos López-Otín
21 [GO] EMBO Molecular Medicine 2022―Sep―12 An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV -2 Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, Kui K. Chan, Savanna S. Skeeters, Christine A. Devlin, Aaron Aguhob, Kristie Shirley, Lijun Rong, Jalees Rehman, Asrar B. Malik, Erik Procko
22 [GO] Molecular Systems Biology 2022―Sep―12 Monocyte-crosstalk drives interferon-mediated signaling following SARS-CoV -2 exposure Sebastian J Theobald, Jan Rybniker
23 [GO] EMBO Reports 2022―Aug―24 Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV -2 spike Diego Cantoni, Matthew J. Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, Spyros Lytras, Jonathon D. Coey, James McKenna, Stephen Bridgett, David Simpson, Derek Fairley, Lucy G. Thorne, Ann-Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Machaela Palor, Lisa Jarvis, Brian Willett, Ultan F. Power, Laura E. McCoy, Clare Jolly, Greg J. Towers, Katie J. Doores, David L. Robertson, Adrian J. Shepherd, Matthew B. Reeves, Connor G. G. Bamford, Joe Grove
24 [GO] EMBO Molecular Medicine 2022―Aug―20 A universal SARS-CoV DNA vaccine inducing highly crossreactive neutralizing antibodies and T cells Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia Larsson, Urban Höglund, Soo Aleman, Friedemann Weber, Emma Perlhamre, Johanna Apro, Eva-Karin Gidlund, Ola Tuvesson, Simona Salati, Matteo Cadossi, Hanna Tegel, Sophia Hober, Lars Frelin, Ali Mirazimi, Matti Sallberg
25 [GO] EMBO Reports 2022―Aug―16 Impaired activation of transposable elements in SARS-CoV -2 infection Matan Sorek, Eran Meshorer, Sharon Schlesinger
26 [GO] Molecular Systems Biology 2022―Aug―04 Non-productive exposure of PBMCs to SARS-CoV -2 induces cell-intrinsic innate immune responses Julia Kazmierski, Kirstin Friedmann, Dylan Postmus, Jackson Emanuel, Cornelius Fischer, Jenny Jansen, Anja Richter, Laure Bosquillon de Jarcy, Christiane Schüler, Madlen Sohn, Sascha Sauer, Christian Drosten, Antoine-Emmanuel Saliba, Leif Erik Sander, Marcel A. Müller, Daniela Niemeyer, Christine Goffinet
27 [GO] EMBO Reports 2022―Jul―28 After 2 years of a pandemic, students are struggling to find strong reference letters David R Smith
28 [GO] EMBO Molecular Medicine 2022―Jul―27 SARS-CoV -2 spike protein enhances MAP4K3 / GLK -induced ACE2 stability in COVID -19 Huai-Chia Chuang, Chia-Hsin Hsueh, Pu-Ming Hsu, Rou-Huei Huang, Ching-Yi Tsai, Nai-Hsiang Chung, Yen-Hung Chow, Tse-Hua Tan
29 [GO] The EMBO Journal 2022―Jul―14 Attenuation of SARS-CoV -2 replication and associated inflammation by concomitant targeting of viral and host cap 2’-O-ribose methyltransferases Valter Bergant, Shintaro Yamada, Vincent Grass, Yuta Tsukamoto, Teresa Lavacca, Karsten Krey, Maria-Teresa Mühlhofer, Sabine Wittmann, Armin Ensser, Alexandra Herrmann, Anja vom Hemdt, Yuriko Tomita, Shutoku Matsuyama, Takatsugu Hirokawa, Yiqi Huang, Antonio Piras, Constanze A. Jakwerth, Madlen Oelsner, Susanne Thieme, Alexander Graf, Stefan Krebs, Helmut Blum, Beate M. Kümmerer, Alexey Stukalov, Carsten B. Schmidt-Weber, Manabu Igarashi, Thomas Gramberg, Andreas Pichlmair, Hiroki Kato
30 [GO] EMBO Molecular Medicine 2022―Jul―04 Clinical grade ACE2 as a universal agent to block SARS-CoV -2 variants Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhöfer, Alice Schwarzböck, Helene Breid, Stephanie Devignot, Jonas Klingström, Charlotte Thålin, Max J Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska-Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M Penninger
31 [GO] EMBO Molecular Medicine 2022―Jul―04 Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination Sebastian J Theobald, Alexander Simonis, Julie M Mudler, Ulrike Göbel, Richard Acton, Viktoria Kohlhas, Marie-Christine Albert, Anna-Maria Hellmann, Jakob J Malin, Sandra Winter, Michael Hallek, Henning Walczak, Phuong-Hien Nguyen, Manuel Koch, Jan Rybniker
32 [GO] EMBO Molecular Medicine 2022―Jul―01 A novel platform for attenuating immune hyperactivity using EXO-CD24 in Covid-19 and beyond Shiran Shapira, Marina Ben Shimon, Mori Hay-Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev-Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber
33 [GO] Molecular Systems Biology 2022―May―17 Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants Diogo Pellegrina, Alexander T Bahcheli, Michal Krassowski, Jüri Reimand
34 [GO] EMBO Molecular Medicine 2022―May―17 Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells Marina Chan, Eric C Holland, Taranjit S Gujral
35 [GO] EMBO Reports 2022―May―12 Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch Ilaria Callegari, Mika Schneider, Giuliano Berloffa, Tobias Mühlethaler, Sebastian Holdermann, Edoardo Galli, Tim Roloff, Renate Boss, Laura Infanti, Nina Khanna, Adrian Egli, Andreas Buser, Gert Zimmer, Tobias Derfuss, Nicholas S R Sanderson
36 [GO] EMBO Reports 2022―May―09 ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion Georg Jocher, Vincent Grass, Sarah K Tschirner, Lydia Riepler, Stephan Breimann, Tuğberk Kaya, Madlen Oelsner, M Sabri Hamad, Laura I Hofmann, Carl P Blobel, Carsten B Schmidt-Weber, Ozgun Gokce, Constanze A Jakwerth, Jakob Trimpert, Janine Kimpel, Andreas Pichlmair, Stefan F Lichtenthaler
37 [GO] The EMBO Journal 2022―Apr―26 Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19 Jennifer Becker, Ulrich Kalinke
38 [GO] EMBO Reports 2022―Apr―25 A human coronavirus OC43-derived polypeptide causes neuropathic pain Veronica I Shubayev, Jennifer Dolkas, Glaucilene Ferreira Catroli, Andrei V Chernov
39 [GO] EMBO Molecular Medicine 2022―Apr―01 SARS-CoV-2 Spike Spurs Intestinal Inflammation via VEGF Production in Enterocytes Fa-min Zeng, Ying-wen Li, Zhao-hua Deng, Jian-zhong He, Wei Li, Lijie Wang, Ting Lyu, Zhanyu Li, Chaoming Mei, Meiling Yang, Ying-ying Dong, Guan-Min Jiang, Xiaofeng Li, Xi Huang, Fei Xiao, Ye Liu, Hong Shan, Huanhuan He
40 [GO] EMBO Molecular Medicine 2022―Mar―14 RNAi to treat SARS-CoV-2-variant proofing the next generation of therapies Nigel A J McMillan, Kevin V Morris, Adi Idris
41 [GO] EMBO Reports 2022―Mar―07 Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance Justin D Walter, Melanie Scherer, Cedric A J Hutter, Alisa A Garaeva, Iwan Zimmermann, Marianne Wyss, Jan Rheinberger, Yelena Ruedin, Jennifer C Earp, Pascal Egloff, Michèle Sorgenfrei, Lea M Hürlimann, Imre Gonda, Gianmarco Meier, Sille Remm, Sujani Thavarasah, Geert van Geest, Rémy Bruggmann, Gert Zimmer, Dirk J Slotboom, Cristina Paulino, Philippe Plattet, Markus A Seeger
42 [GO] EMBO Reports 2022―Mar―03 A simple reverse genetics method to generate recombinant coronaviruses Julien Mélade, Géraldine Piorkowski, Franck Touret, Toscane Fourié, Jean-Sélim Driouich, Maxime Cochin, Hawa Sophia Bouzidi, Bruno Coutard, Antoine Nougairède, Xavier Lamballerie
43 [GO] EMBO Molecular Medicine 2022―Feb―25 COVID-19 vaccination, time for a second breath? Christiane E Gerke, Bernd Pulverer, Philippe J Sansonetti
44 [GO] EMBO Reports 2022―Feb―23 Lamarck redux and other false arguments against SARS-CoV-2 vaccination Emanuel Goldman
45 [GO] The EMBO Journal 2022―Feb―18 TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection Renée M. van der Sluis, Lamin B. Cham, Albert Gris-Oliver, Kristine R. Gammelgaard, Jesper G. Pedersen, Manja Idorn, Ulvi Ahmadov, Sabina Sanches Hernandez, Ena Cémalovic, Stine H. Godsk, Jacob Thyrsted, Jesper D. Gunst, Silke D. Nielsen, Janni J. Jørgensen, Tobias Wang Bjerg, Anders Laustsen, Line S. Reinert, David Olagnier, Rasmus O. Bak, Mads Kjolby, Christian K. Holm, Martin Tolstrup, Søren R. Paludan, Lasse S. Kristensen, Ole S. Søgaard, Martin R. Jakobsen
46 [GO] Molecular Systems Biology 2022―Feb―14 High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein Rohit Suratekar, Pritha Ghosh, Michiel J M Niesen, Gregory Donadio, Praveen Anand, Venky Soundararajan, A J Venkatakrishnan
47 [GO] EMBO Molecular Medicine 2022―Feb―09 A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant Yi-Chung Chang, Chi-Fan Yang, Yi-Fen Chen, Chia-Chun Yang, Yuan-Lin Chou, Hung-Wen Chou, Tein-Yao Chang, Tai-Ling Chao, Shu-Chen Hsu, Si-Man Ieong, Ya-Min Tsai, Ping-Cheng Liu, Yuan-Fan Chin, Jun-Tung Fang, Han-Chieh Kao, Hsuan-Ying Lu, Jia-Yu Chang, Ren-Shiuan Weng, Qian-Wen Tu, Fang-Yu Chang, Kuo-Yen Huang, Tong-Young Lee, Sui-Yuan Chang, Pan-Chyr Yang
48 [GO] EMBO Molecular Medicine 2022―Jan―27 SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance Xavier Montagutelli, Sylvie van der Werf, Felix A Rey, Etienne Simon-Loriere
49 [GO] EMBO Molecular Medicine 2022―Jan―07 Decreased memory B cells frequencies in COVID-19 Delta variant vaccine breakthrough infection Matthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, Yun Shan Goh, Yi-Hao Chan, Zi Wei Chang, Weili Xu, Chee Wah Tan, Wan Ni Chia, Anthony Torres-Ruesta, Siti Naqiah Amrun, Yuling Huang, Pei Xiang Hor, Chiew Yee Loh, Nicholas Kim-Wah Yeo, Bei Wang, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Jean-Marc Chavatte, Alicia Jieling Lim, Sebastian Maurer-Stroh, Lin-Fa Wang, Raymond TP Lin, Cheng-I Wang, Seow-Yen Tan, Barnaby Edward Young, Yee-Sin Leo, David C Lye, Laurent Renia, Lisa F P Ng
50 [GO] The EMBO Journal 2022―Jan―04 Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia, Chengpeng Qiao, Jianxun Qi, Wen-xia Tian, Hong-Wei Wang, Qihui Wang, George Fu Gao
51 [GO] Molecular Systems Biology 2021―Dec―23 COVID-19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert Phair, Aurelio Orta-Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Marcio Luis Acencio, Enrico Glaab, Andreas Ruepp, Gisela Fobo, Corinna Montrone, Barbara Brauner, Goar Frishman, Luis Cristóbal Monraz Gómez, Julia Somers, Matti Hoch, Shailendra Kumar Gupta, Julia Scheel, Hanna Borlinghaus, Tobias Czauderna, Falk Schreiber, Arnau Montagud, Miguel Ponce de Leon, Akira Funahashi, Yusuke Hiki, Noriko Hiroi, Takahiro G Yamada, Andreas Dräger, Alina Renz, Muhammad Naveez, Zsolt Bocskei, Francesco Messina, Daniela Börnigen, Liam Fergusson, Marta Conti, Marius Rameil, Vanessa Nakonecnij, Jakob Vanhoefer, Leonard Schmiester, Muying Wang, Emily E Ackerman, Jason E Shoemaker, Jeremy Zucker, Kristie Oxford, Jeremy Teuton, Ebru Kocakaya, Gökçe Yağmur Summak, Kristina Hanspers, Martina Kutmon, Susan Coort, Lars Eijssen, Friederike Ehrhart, D A B Rex, Denise Slenter, Marvin Martens, Nhung Pham, Robin Haw, Bijay Jassal, Lisa Matthews, Marija Orlic-Milacic, Andrea Senff-Ribeiro, Karen Rothfels, Veronica Shamovsky, Ralf Stephan, Cristoffer Sevilla, Thawfeek Varusai, Jean-Marie Ravel, Rupsha Fraser, Vera Ortseifen, Silvia Marchesi, Piotr Gawron, Ewa Smula, Laurent Heirendt, Venkata Satagopam, Guanming Wu, Anders Riutta, Martin Golebiewski, Stuart Owen, Carole Goble, Xiaoming Hu, Rupert W Overall, Dieter Maier, Angela Bauch, Benjamin M Gyori, John A Bachman, Carlos Vega, Valentin Grouès, Miguel Vazquez, Pablo Porras, Luana Licata, Marta Iannuccelli, Francesca Sacco, Anastasia Nesterova, Anton Yuryev, Anita de Waard, Denes Turei, Augustin Luna, Ozgun Babur, Sylvain Soliman, Alberto Valdeolivas, Marina Esteban-Medina, Maria Peña-Chilet, Kinza Rian, Tomáš Helikar, Bhanwar Lal Puniya, Dezso Modos, Agatha Treveil, Marton Olbei, Bertrand De Meulder, Stephane Ballereau, Aurélien Dugourd, Aurélien Naldi, Vincent Noël, Laurence Calzone, Chris Sander, Emek Demir, Tamas Korcsmaros, Tom C Freeman, Franck Augé, Jacques S Beckmann, Jan Hasenauer, Olaf Wolkenhauer, Egon L Willighagen, Alexander R Pico, Chris T Evelo, Marc E Gillespie, Lincoln D Stein, Henning Hermjakob, Peter D'Eustachio, Julio Saez-Rodriguez, Joaquin Dopazo, Alfonso Valencia, Hiroaki Kitano, Emmanuel Barillot, Charles Auffray, Rudi Balling, Reinhard Schneider
52 [GO] EMBO Reports 2021―Dec―20 Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern Teresa R Wagner, Daniel Schnepf, Julius Beer, Natalia Ruetalo, Karin Klingel, Philipp D Kaiser, Daniel Junker, Martina Sauter, Bjoern Traenkle, Desiree I Frecot, Matthias Becker, Nicole Schneiderhan-Marra, Annette Ohnemus, Martin Schwemmle, Michael Schindler, Ulrich Rothbauer
53 [GO] EMBO Reports 2021―Dec―16 A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, Marco Vignuzzi, Sylvie van der Werf, Sylvie Behillil, Flora Donati, Nathalie Sauvonnet, Giulia Nigro, Maryline Bourgine, Nolwenn Jouvenet, Germano Cecere
54 [GO] EMBO Molecular Medicine 2021―Dec―04 Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Samples Emily A. Bruce, Margaret G. Mills, Reigran Sampoleo, Garrett A. Perchetti, Meei-Li Huang, Hannah W. Despres, Madaline M. Schmidt, Pavitra Roychoudhury, David J. Shirley, Keith R. Jerome, Alexander L. Greninger, Jason W. Botten
55 [GO] EMBO Reports 2021―Dec―02 DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging Sara Sepe, Francesca Rossiello, Valeria Cancila, Fabio Iannelli, Valentina Matti, Giada Cicio, Matteo Cabrini, Eugenia Marinelli, Busola R Alabi, Alessia di Lillo, Arianna Di Napoli, Jerry W Shay, Claudio Tripodo, Fabrizio d’Adda di Fagagna
56 [GO] The EMBO Journal 2021―Nov―15 SARS-CoV-2 variants as super cell fusers: cause or consequence of COVID-19 severity? Jana Koch, Zina M Uckeley, Pierre-Yves Lozach
57 [GO] EMBO Molecular Medicine 2021―Nov―08 High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti
58 [GO] Molecular Systems Biology 2021―Oct―28 SARS-CoV-2-host proteome interactions for antiviral drug discovery Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, Taras Redchuk, Mariia Bogacheva, Kari Salokas, Ina Pöhner, Tiina Öhman, Arun Kumar Tonduru, Antti Hassinen, Lisa Gawriyski, Salla Keskitalo, Maria K Vartiainen, Vilja Pietiäinen, Antti Poso, Markku Varjosalo
59 [GO] Molecular Systems Biology 2021―Oct―28 Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets Kuoyuan Cheng, Laura Martin-Sancho, Lipika R Pal, Yuan Pu, Laura Riva, Xin Yin, Sanju Sinha, Nishanth Ulhas Nair, Sumit K Chanda, Eytan Ruppin
60 [GO] EMBO Molecular Medicine 2021―Oct―21 Flower lose, a cell fitness marker, predicts COVID-19 prognosis Michail Yekelchyk, Esha Madan, Jochen Wilhelm, Kirsty R Short, António M Palma, Linbu Liao, Denise Camacho, Everlyne Nkadori, Michael T Winters, Emily S Rice, Inês Rolim, Raquel Cruz-Duarte, Christopher J Pelham, Masaki Nagane, Kartik Gupta, Sahil Chaudhary, Thomas Braun, Raghavendra Pillappa, Mark S Parker, Thomas Menter, Matthias Matter, Jasmin Dionne Haslbauer, Markus Tolnay, Kornelia D Galior, Kristina A Matkwoskyj, Stephanie M McGregor, Laura K Muller, Emad A Rakha, Antonio Lopez-Beltran, Ronny Drapkin, Maximilian Ackermann, Paul B Fisher, Steven R Grossman, Andrew K Godwin, Arutha Kulasinghe, Ivan Martinez, Clay B Marsh, Benjamin Tang, Max S Wicha, Kyoung Jae Won, Alexandar Tzankov, Eduardo Moreno, Rajan Gogna
61 [GO] EMBO Molecular Medicine 2021―Oct―21 Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Hebang Yao, Liu Daisy Liu, Zhou Sun, Martje Fentener van Vlissingen, Thijs Kuiken, Corine H. GeurtsvanKessel, Ning Zhang, Bingjie Zhou, Lu Lu, Yuhuan Gong, Wenming Qin, Moumita Mondal, Bowen Duan, Shiqi Xu, Audrey S Richard, Hervé Raoul, JianFeng Chen, Chenqi Xu, Ligang Wu, Haisheng Zhou, Zhong Huang, Xuechao Zhang, Jun Li, Yanyan Wang, Yuhai Bi, Barry Rockx, Junfang Chen, Fei-Long Meng, Dimitri Lavillette, Dianfan Li
62 [GO] EMBO Molecular Medicine 2021―Oct―16 Brain Cross-Protection against SARS-CoV-2 Variants by a Lentiviral Vaccine in New Transgenic Mice Min-Wen Ku, Pierre Authié, Maryline Bourgine, François Anna, Amandine Noirat, Fanny Moncoq, Benjamin Vesin, Fabien Nevo, Jodie Lopez, Philippe Souque, Catherine Blanc, Ingrid Fert, Sébastien Chardenoux, llta Lafosse, Delphine Cussigh, David Hardy, Kirill Nemirov, Françoise Guinet, Francina Langa Vives, Laleh Majlessi, Pierre Charneau
63 [GO] The EMBO Journal 2021―Oct―04 SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Remy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers, Marija Zivaljic, Cyril Planchais, Florence Guivel-Benhassine, Françoise Porrot, Hugo Mouquet, Lisa A Chakrabarti, Julian Buchrieser, Olivier Schwartz
64 [GO] EMBO Reports 2021―Sep―17 Lessons from COVID-19 Philip Hunter
65 [GO] EMBO Molecular Medicine 2021―Sep―17 Racing for a SARS-CoV-2 vaccine Özlem Türeci, Uğur Şahin
66 [GO] Molecular Systems Biology 2021―Sep―14 SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms Seán I O’Donoghue, Andrea Schafferhans, Neblina Sikta, Christian Stolte, Sandeep Kaur, Bosco K Ho, Stuart Anderson, James B Procter, Christian Dallago, Nicola Bordin, Matt Adcock, Burkhard Rost
67 [GO] The EMBO Journal 2021―Sep―12 Infection and transmission of SARS-CoV-2 depends on heparan sulfate proteoglycans Marta Bermejo-Jambrina, Julia Eder, Tanja M. Kaptein, John L. van Hamme, Leanne C. Helgers, Killian E. Vlaming, Philip J.M. Brouwer, Ad C. van Nuenen, Marcel Spaargaren, Godelieve J. de Bree, Bernadien M. Nijmeijer, Neeltje A. Kootstra, Marit J. van Gils, Rogier W. Sanders, Teunis B. H. Geijtenbeek
68 [GO] EMBO Reports 2021―Sep―07 How many animals are used for SARS-CoV-2 research? Philipp Schwedhelm, Johanna Kusnick, Céline Heinl, Gilbert Schönfelder, Bettina Bert
69 [GO] EMBO Reports 2021―Sep―03 COVID-19 and the gain of function debates Kelsey Lane Warmbrod, Michael G Montague, Gigi Kwik Gronvall
70 [GO] Molecular Systems Biology 2021―Aug―13 Machine Learning Identifies Molecular Regulators and Therapeutics for Targeting SARS-CoV2-induced Cytokine Release Marina Chan, Siddharth Vijay, John McNevin, M. Juliana McElrath, Eric C. Holland, Taranjit S Gujral
71 [GO] The EMBO Journal 2021―Aug―10 Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites David Hoffmann, Stefan Mereiter, Yoo Jin Oh, Vanessa Monteil, Elizabeth Elder, Rong Zhu, Daniel Canena, Lisa Hain, Elisabeth Laurent, Clemens Grünwald-Gruber, Miriam Klausberger, Gustav Jonsson, Max J. Kellner, Maria Novatchkova, Melita Ticevic, Antoine Chabloz, Gerald Wirnsberger, Astrid Hagelkruys, Friedrich Altmann, Lukas Mach, Johannes Stadlmann, Chris Oostenbrink, Ali Mirazimi, Peter Hinterdorfer, Josef M. Penninger
72 [GO] Molecular Systems Biology 2021―Aug―02 A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection Fangyuan Chen, Qingya Shi, Fen Pei, Andreas Vogt, Rebecca A Porritt, Gustavo Garcia, Angela C Gomez, Mary Hongying Cheng, Mark E Schurdak, Bing Liu, Stephen Y Chan, Vaithilingaraja Arumugaswami, Andrew M Stern, D Lansing Taylor, Moshe Arditi, Ivet Bahar
73 [GO] The EMBO Journal 2021―Jul―29 A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein Anna Albecka, Dean Clift, Marina Vaysburd, Tyler Rhinesmith, Sarah L Caddy, David M Favara, Helen E Baxendale, Leo C James
74 [GO] The EMBO Journal 2021―Jul―24 Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies Thomas Güttler, Metin Aksu, Antje Dickmanns, Kim M. Stegmann, Kathrin Gregor, Renate Rees, Waltraud Taxer, Oleh Rymarenko, Jürgen Schünemann, Christian Dienemann, Philip Gunkel, Bianka Mussil, Jens Krull, Ulrike Teichmann, Uwe Groß, Volker C. Cordes, Matthias Dobbelstein, Dirk Görlich
75 [GO] The EMBO Journal 2021―Jul―23 SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage Juan Ma, Fangrui Zhu, Min Zhao, Fei Shao, Dou Yu, Jiangwen Ma, Xusheng Zhang, Weitao Li, Yan Qian, Yan Zhang, Dong Jiang, Shuo Wang, Pengyan Xia
76 [GO] EMBO Molecular Medicine 2021―Jul―14 Individual COVID-19 disease trajectories revealed by plasma proteomics Danish Memon, Inigo Barrio-Hernandez, Pedro Beltrao
77 [GO] EMBO Molecular Medicine 2021―Jul―07 High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion Philipp E Geyer, Florian M Arend, Sophia Doll, Marie-Luise Louiset, Sebastian Virreira Winter, Johannes B Müller-Reif, Furkan M Torun, Michael Weigand, Peter Eichhorn, Mathias Bruegel, Maximilian T Strauss, Lesca M Holdt, Matthias Mann, Daniel Teupser
78 [GO] The EMBO Journal 2021―Jul―07 Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis Zhen Chen, Chao Wang, Xu Feng, Litong Nie, Mengfan Tang, Huimin Zhang, Yun Xiong, Samuel K. Swisher, Mrinal Srivastava, Junjie Chen
79 [GO] EMBO Molecular Medicine 2021―Jun―25 Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, Lena Feige, Etienne Kornobis, Sylvain Levallois, Agnès Marchio, Lauriane Kergoat, David Hardy, Thomas Cokelaer, Pascal Pineau, Marc Lecuit, Pierre-Marie Lledo, Jean-Pierre Changeux, Hervé Bourhy
80 [GO] The EMBO Journal 2021―Jun―23 TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells Jana Koch, Zina M Uckeley, Patricio Doldan, Megan Stanifer, Steeve Boulant, Pierre-Yves Lozach
81 [GO] EMBO Molecular Medicine 2021―Jun―16 Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19 Sebastian J Theobald, Alexander Simonis, Theodoros Georgomanolis, Christoph Kreer, Matthias Zehner, Hannah S Eisfeld, Marie-Christine Albert, Jason Chhen, Susanne Motameny, Florian Erger, Julia Fischer, Jakob J Malin, Jessica Gräb, Sandra Winter, Andromachi Pouikli, Friederike David, Boris Böll, Philipp Koehler, Kanika Vanshylla, Henning Gruell, Isabelle Suárez, Michael Hallek, Gerd Fätkenheuer, Norma Jung, Oliver A Cornely, Clara Lehmann, Peter Tessarz, Janine Altmüller, Peter Nürnberg, Hamid Kashkar, Florian Klein, Manuel Koch, Jan Rybniker
82 [GO] The EMBO Journal 2021―Jun―08 SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation Lucy G Thorne, Ann-Kathrin Reuschl, Lorena Zuliani-Alvarez, Matthew V.X. Whelan, Jane Turner, Mahdad Noursadeghi, Clare Jolly, Greg J Towers
83 [GO] EMBO Reports 2021―May―25 The COVID-19 pandemic: agile versus blundering communication during a worldwide crisis Gaby-Fleur Böl
84 [GO] The EMBO Journal 2021―May―21 Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin Sheng Niu, Jia Wang, Bin Bai, Lili Wu, Anqi Zheng, Qian Chen, Pei Du, Pengcheng Han, Yanfang Zhang, Yunfei Jia, Chengpeng Qiao, Jianxun Qi, Wen-xia Tian, Hong-Wei Wang, Qihui Wang, George Fu Gao
85 [GO] EMBO Molecular Medicine 2021―May―09 Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, Guillaume Carissimo, Nicholas Kim-Wah Yeo, Siti Naqiah Amrun, Yun Shan Goh, Jackwee Lim, Weili Xu, Rhonda Sin-Ling Chee, Anthony Torres-Ruesta, Cheryl Yi-Pin Lee, Matthew Zirui Tay, Zi Wei Chang, Wen-Hsin Lee, Bei Wang, Seow-Yen Tan, Shirin Kalimuddin, Barnaby Edward Young, Yee-Sin Leo, Cheng-I Wang, Bernett Lee, Olaf Rötzschke, David Chien Lye, Laurent Renia, Lisa F.P. Ng
86 [GO] EMBO Molecular Medicine 2021―May―01 SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course Study - Potential Challenge for Vaccines and Therapies Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler
87 [GO] EMBO Reports 2021―Apr―28 Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-chip model Vivek V Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet-Dessimoz, John D McKinney
88 [GO] Molecular Systems Biology 2021―Apr―27 Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut Sergio Triana, Camila Metz-Zumaran, Carlos Ramirez, Carmon Kee, Patricio Doldan, Mohammed Shahraz, Daniel Schraivogel, Andreas R Gschwind, Ashwini K Sharma, Lars M Steinmetz, Carl Herrmann, Theodore Alexandrov, Steeve Boulant, Megan L Stanifer
89 [GO] EMBO Reports 2021―Apr―27 NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies Teresa R Wagner, Elena Ostertag, Philipp D Kaiser, Marius Gramlich, Natalia Ruetalo, Daniel Junker, Julia Haering, Bjoern Traenkle, Matthias Becker, Alex Dulovic, Helen Schweizer, Stefan Nueske, Armin Scholz, Anne Zeck, Katja Schenke-Layland, Annika Nelde, Monika Strengert, Juliane S Walz, Georg Zocher, Thilo Stehle, Michael Schindler, Nicole Schneiderhan-Marra, Ulrich Rothbauer
90 [GO] The EMBO Journal 2021―Apr―21 The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation Jian Lei, Yue Ma-Lauer, Yinze Han, Matthias Thoms, Robert Buschauer, Joerg Jores, Volker Thiel, Roland Beckmann, Wen Deng, Heinrich Leonhardt, Rolf Hilgenfeld, Albrecht von Brunn
91 [GO] EMBO Molecular Medicine 2021―Mar―31 High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti
92 [GO] EMBO Reports 2021―Mar―24 COVID-19 and the opportunities for research Philip Hunter
93 [GO] EMBO Reports 2021―Feb―22 A CRISPR response to pandemics? Federico Germani, Sebastian Wäscher, Nikola Biller-Andorno
94 [GO] Molecular Systems Biology 2021―Feb―19 SARS-CoV-2 infection remodels the host protein thermal stability landscape Joel Selkrig, Megan Stanifer, André Mateus, Karin Mitosch, Inigo Barrio-Hernandez, Mandy Rettel, Heeyoung Kim, Carlos G P Voogdt, Philipp Walch, Carmon Kee, Nils Kurzawa, Frank Stein, Clément Potel, Anna Jarzab, Bernhard Kuster, Ralf Bartenschlager, Steeve Boulant, Pedro Beltrao, Athanasios Typas, Mikhail M Savitski
95 [GO] The EMBO Journal 2021―Feb―14 Halting SARS-CoV-2: lung organoids step up to the plate Sandra L Leibel, Xin Sun
96 [GO] EMBO Molecular Medicine 2021―Feb―06 Epithelial response to IFN-γ promotes SARS-CoV-2 infection Julian Heuberger, Jakob Trimpert, Daria Vladimirova, Christian Goosmann, Manqiang Lin, Rosa Schmuck, Hans-Joachim Mollenkopf, Volker Brinkmann, Frank Tacke, Nikolaus Osterrieder, Michael Sigal
97 [GO] The EMBO Journal 2021―Feb―01 Syncytia formation by SARS-CoV-2-infected cells Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf, Nicoletta Casartelli, Hugo Mouquet, Timothée Bruel, Olivier Schwartz
98 [GO] EMBO Molecular Medicine 2021―Jan―20 Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein Lydia Horndler, Pilar Delgado, David Abia, Ivaylo Balabanov, Pedro Martínez-Fleta, Georgina Cornish, Miguel A. Llamas, Sergio Serrano-Villar, Francisco Sánchez-Madrid, Manuel Fresno, Hisse M. van Santen, Balbino Alarcón
99 [GO] EMBO Molecular Medicine 2020―Dec―17 The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections Hugh Rosen, Michael B A Oldstone
100 [GO] The EMBO Journal 2020―Dec―07 An Organoid-derived Bronchioalveolar Model for SARS-CoV-2 Infection of Human Alveolar-type II-like Cells Mart M. Lamers, Jelte van der Vaart, Kèvin Knoops, Samra Riesebosch, Tim I. Breugem, Anna Z. Mykytyn, Joep Beumer, Debby Schipper, Karel Bezstarosti, Charlotte D. Koopman, Nathalie Groen, Raimond B.G. Ravelli, Hans Q. Duimel, Jeroen A.A. Demmers, Georges M.G.M. Verjans, Marion P.G. Koopmans, Mauro J. Muraro, Peter J. Peters, Hans Clevers, Bart L. Haagmans
101 [GO] The EMBO Journal 2020―Dec―03 Opposing activities of IFITM proteins in SARS-CoV-2 infection Guoli Shi, Adam D. Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, Luanne Hall-Stoodley, Richard T. Robinson, Dmitri S. Kudryashov, Alex A. Compton, Jacob S. Yount
102 [GO] The EMBO Journal 2020―Nov―17 SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs Theodora Myrto Perdikari, Anastasia C. Murthy, Veronica H. Ryan, Scott Watters, Mandar T. Naik, Nicolas L. Fawzi
103 [GO] EMBO Molecular Medicine 2020―Nov―15 Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19 Giovanni Marfia, Stefania Navone, Laura Guarnaccia, Rolando Campanella, Michele Mondoni, Marco Locatelli, Alessandra Barassi, Laura Fontana, Fabrizio Palumbo, Emanuele Garzia, Giuseppe Ciniglio Appiani, Davide Chiumello, Monica Miozzo, Stefano Centanni, Laura Riboni
104 [GO] EMBO Molecular Medicine 2020―Nov―12 Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection Vanessa Monteil, Matheus Dyczynski, Volker M Lauschke, Hyesoo Kwon, Gerald Wirnsberger, Sonia Youhanna, Haibo Zhang, Arthur S.Slutsky, Carmen Hurtado del Pozo, Moritz Horn, Nuria Montserrat, Josef M. Penninger, Ali Mirazimi
105 [GO] The EMBO Journal 2020―Nov―11 COVID-19 lessons from the dish: Dissecting CNS manifestations through brain organoids Nicolò Caporale, Giuseppe Testa
106 [GO] EMBO Molecular Medicine 2020―Nov―07 Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection Kuo-Yen Huang, Ming-Shiu Lin, Ting-Chun Kuo, Ci-Ling Chen, Chung-Chih Lin, Yu-Chi Chou, Tai-Ling Chao, Yu-Hao Pang, Han-Chieh Kao, Rih-Sheng Huang, Steven Lin, Sui-Yuan Chang, Pan-Chyr Yang
107 [GO] The EMBO Journal 2020―Nov―03 Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage Yan-Mei Chen, Yuanting Zheng, Ying Yu, Yunzhi Wang, Qingxia Huang, Feng Qian, Lei Sun, Zhi-Gang Song, Ziyin Chen, Jinwen Feng, Yanpeng An, Jingcheng Yang, Zhenqiang Su, Shanyue Sun, Fahui Dai, Qinsheng Chen, Qinwei Lu, Pengcheng Li, Yun Ling, Zhong Yang, Huiru Tang, Leming Shi, Li Jin, Edward C. Holmes, Chen Ding, Tong-Yu Zhu, Yong-Zhen Zhang
108 [GO] EMBO Reports 2020―Oct―28 SARS-CoV-2 evades immune detection in alveolar macrophages Louise Dalskov, Michelle Møhlenberg, Jacob Thyrsted, Julia Blay-Cadanet, Ebbe Toftgaard Poulsen, Birgitte Holst Folkersen, Søren Helbo Skaarup, David Olagnier, Line Reinert, Jan Johannes Enghild, Hans Jürgen Hoffmann, Christian Kanstrup Holm, Rune Hartmann
109 [GO] EMBO Molecular Medicine 2020―Oct―20 Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia Lara Gibellini, Sara De Biasi, Annamaria Paolini, Rebecca Borella, Federica Boraldi, Marco Mattioli, Domenico Lo Tartaro, Lucia Fidanza, Alfredo Caro-Maldonado, Marianna Meschiari, Vittorio Iadisernia, Erica Bacca, Giovanni Riva, Luca Cicchetti, Daniela Quaglino, Giovanni Guaraldi, Stefano Busani, Massimo Girardis, Cristina Mussini, Andrea Cossarizza
110 [GO] EMBO Molecular Medicine 2020―Oct―19 COVID -19 pandemic-related lockdown: response time is more important than its strictness Gil Loewenthal, Shiran Abadi, Oren Avram, Keren Halabi, Noa Ecker, Natan Nagar, Itay Mayrose, Tal Pupko
111 [GO] The EMBO Journal 2020―Oct―14 Syncytia formation by SARS-CoV-2 infected cells Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf, Nicoletta Casartelli, Hugo Mouquet, Timothée Bruel, Olivier Schwartz
112 [GO] EMBO Molecular Medicine 2020―Oct―05 A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2 Alexander Simonis, Sebastian J. Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J. Malin
113 [GO] EMBO Molecular Medicine 2020―Oct―04 SARS-CoV-2 outbreak investigation in a German meat processing plant Thomas Günther, Manja Czech-Sioli, Daniela Indenbirken, Alexis Robitaille, Peter Tenhaken, Martin Exner, Matthias Ottinger, Nicole Fischer, Adam Grundhoff, Melanie M. Brinkmann
114 [GO] EMBO Molecular Medicine 2020―Sep―30 COVID-19: A Pandemic Experience that Illuminates Potential Reforms to Health Research Hannah N. Kozlowski, Michael E. Farkouh, Meredith S. Irwin, Laszlo G. Radvanyi, Aaron D. Schimmer, Uri Tabori, Norman D. Rosenblum
115 [GO] The EMBO Journal 2020―Sep―22 Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design Ya Peng, Ning Du, Yuqing Lei, Sonam Dorje, Jianxun Qi, Tingrong Luo, George F Gao, Hao Song
116 [GO] The EMBO Journal 2020―Sep―22 SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells Soeren Lukassen, Robert Lorenz Chua, Timo Trefzer, Nicolas C Kahn, Marc A Schneider, Thomas Muley, Hauke Winter, Michael Meister, Carmen Veith, Agnes W Boots, Bianca P Hennig, Michael Kreuter, Christian Conrad, Roland Eils
117 [GO] The EMBO Journal 2020―Sep―18 Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and coronaviruses by depleting membrane cholesterol Shaobo Wang, Wanyu Li, Hui Hui, Shashi Kant Tiwari, Qiong Zhang, Ben A. Croker, Stephen Rawlings, Davey Smith, Aaron F. Carlin, Tariq M. Rana
118 [GO] The EMBO Journal 2020―Sep―02 SARS-CoV-2 targets neurons of 3D human brain organoids Anand Ramani, Lisa Müller, Philipp Niklas Ostermann, Elke Gabriel, Pranty Abida-Islam, Andreas Müller-Schiffmann, Aruljothi Mariappan, Olivier Goureau, Henning Gruell, Andreas Walker, Marcel Andrée, Sandra Hauka, Torsten Houwaart, Alexander Dilthey, Kai Wohlgemuth, Heymut Omran, Florian Klein, Dagmar Wieczorek, Ortwin Adams, Jörg Timm, Carsten Korth, Heiner Schaal, Jay Gopalakrishnan
119 [GO] The EMBO Journal 2020―Aug―26 Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2 Theresa Klemm, Gregor Ebert, Dale J Calleja, Cody C Allison, Lachlan W Richardson, Jonathan P Bernardini, Bernadine GC Lu, Nathan W Kuchel, Christoph Grohmann, Yuri Shibata, Zhong Yan Gan, James P Cooney, Marcel Doerflinger, Amanda E Au, Timothy R Blackmore, Gerbrand J Heden van Noort, Paul P Geurink, Huib Ovaa, Janet Newman, Alan Riboldi-Tunnicliffe, Peter E Czabotar, Jeffrey P Mitchell, Rebecca Feltham, Bernhard C Lechtenberg, Kym N Lowes, Grant Dewson, Marc Pellegrini, Guillaume Lessene, David Komander
120 [GO] EMBO Molecular Medicine 2020―Aug―20 Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes Fawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal-Trecan, Ronan Roussel, Jean-Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean-François Gautier
121 [GO] EMBO Reports 2020―Aug―12 Data protection during the coronavirus crisis Christophe Olivier Schneble, Bernice Simone Elger, David Martin Shaw
122 [GO] EMBO Molecular Medicine 2020―Jun―23 Can artificial intelligence identify effective COVID-19 therapies? Michael B. Schultz, Daniel Vera, David A. Sinclair
123 [GO] EMBO Molecular Medicine 2020―Jun―19 Rationale for targeting Complement in COVID-19 Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda S Klavinskis, Steven Sacks
124 [GO] EMBO Molecular Medicine 2020―Jun―19 Autopsy registry can facilitate COVID-19 research Saskia von Stillfried, Roman David Bülow, Rainer Röhrig, Ruth Knüchel-Clarke, Peter Boor
125 [GO] EMBO Molecular Medicine 2020―May―30 Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J. Richardson, Vanessa Monteil, Volker M. Lauschke, Ali Mirazimi, Sonia Youhanna, Yee-Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge A. Ross Terres, Brian J. Nickoloff, Richard E. Higgs, Guilherme Rocha, Nicole L. Byers, Douglas E. Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino
126 [GO] EMBO Molecular Medicine 2020―May―19 The role of interleukin-6 in monitoring severe case of coronavirus disease 2019 Tao Liu, Jieying Zhang, Yuhui Yang, Hong Ma, Zhenyu Li, Jiaoyue Zhang, Ji Cheng, Xiaoyun Zhang, Yanxia Zhao, Zihan Xia, Liling Zhang, Gang Wu, Jianhua Yi
127 [GO] EMBO Molecular Medicine 2020―May―07 Is BCG vaccination causally related to reduced COVID-19 mortality? Masayuki Miyasaka
128 [GO] EMBO Molecular Medicine 2020―May―06 ‘All In’: A Pragmatic Framework for COVID-19 Testing and Action on a Global Scale SD Pettit, KR Jerome, D Rouquie, B Mari, P Barbry, Y Kanda, M Matsumoto, S Hester, L Wehmas, JW Botten, EA Bruce
129 [GO] EMBO Molecular Medicine 2020―Apr―25 COVID-19: lambda interferon against viral load and hyperinflammation Evangelos Andreakos, Sotirios Tsiodras
130 [GO] EMBO Molecular Medicine 2020―Apr―20 COVID-19, chronicle of an expected pandemic Philippe Sansonetti
131 [GO] EMBO Molecular Medicine 2020―Apr―17 The prospects for the SARS-CoV-2 pandemic in Africa Virginia Quaresima, Matteo M. Naldini, Daniela M. Cirillo
132 [GO] EMBO Reports 2020―Mar―17 The spread of the COVID -19 coronavirus Philip Hunter
 [1] 

132 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec